Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.820
+0.620 (14.76%)
Apr 17, 2026, 4:08 PM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 934.35 million as of April 17, 2026. Its market cap has increased by 8.31% in one year.
Market Cap
934.35M
Enterprise Value
965.17M
Revenue
85.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.82
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 934.35M, a decrease of -69.74%. That is a compound annual growth rate of -37.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 934.35M | -39.90% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.57B |
| Kintor Pharmaceutical | 1.46B |
| Beijing Biostar Pharmaceuticals | 1.40B |
| Transcenta Holding | 1.26B |
| Brii Biosciences | 1.02B |
| Shanghai Bio-heart Biological Technology | 1.02B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 961.36M |